Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glaucoma Associates of Texas (GAT) is a premier ophthalmology practice specializing in the medical and surgical management of glaucoma and cataracts. Established in 1983, the group is recognized globally for its expertise in complex surgical interventions, including trabeculectomy, aqueous shunts, and minimally invasive glaucoma surgery (MIGS). Beyond patient care, GAT serves as a significant clinical research hub, participating in numerous Phase 1-4 clinical trials for innovative ophthalmic drugs and surgical devices. The practice operates several state-of-the-art facilities across the Dallas-Fort Worth metroplex, providing comprehensive diagnostic and therapeutic services. Through its physicians' pioneering work, GAT has been instrumental in developing novel techniques such as gonioscopy-assisted transluminal trabeculotomy (GATT).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glaucoma Associates of Texas.